Immunomic Therapeutics, Inc.
Clinical trials sponsored by Immunomic Therapeutics, Inc., explained in plain language.
-
New RNA vaccine aims to stop breast cancer return
Disease control Recruiting nowThis early-stage trial tests an investigational cancer vaccine called ITI-5000 in 60 people with stage II-III triple-negative breast cancer who have finished standard treatment. The vaccine uses self-amplifying RNA to teach the immune system to attack cancer cells. The study firs…
Phase: PHASE1 • Sponsor: Immunomic Therapeutics, Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can an RNA shot teach the immune system to ignore cedar pollen?
Symptom relief Recruiting nowThis early-stage trial tests an experimental RNA immunotherapy called ITI-9001 in adults with Japanese cedar pollen allergy. The treatment aims to retrain the immune system to reduce allergic reactions. Researchers are primarily checking safety and how well people tolerate the sh…
Phase: PHASE1 • Sponsor: Immunomic Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC